Globalworld globe
United Kingdom
North America
Europe
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
    • Medical Devices
    • Veterinary
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

Investors/Media

Shareholders are an essential asset to any business. Through their financial investment into the future of the company, MVP can invest in developing new products, exploring opportunities in international markets and building a business which will reward them with significant returns.

As a company listed on the ASX, MVP has the responsibility to report to their shareholders through annual reports and ASX announcements. All shareholder information is now available here with links and downloadable reports.

If you would like to invest in MDI shares, the ASX code is MVP, so contact your broker for more details.

US FDA Investor Presentation

View the Investor presentation (3rd March 2022).

FY22 Half Year Results

MVP’s Half Year Results were released on Thursday, 24 February 2022.

A recording of the CEO Investor Presentation held on Friday, 25 February 2022 is provided below.

ASX Announcements

The following are downloads of MVP’s announcements to the ASX (please note that purely technical/compliance related notices are not posted here, but can be obtained from the ASX at www.asx.com.au if required).

For 2022 announcements please click here

CEO Investor Presentation

For the latest MVP CEO Investor Presentation slides, please click on the following – MVP FY22 HY Investor Presentation

A recording of the presentation can also be viewed below

ASX Share Information

Loading

Please Note: Price data in the above table is delayed by at least 20 minutes as required by the ASX. View MVP on ASX website.

  • Investors/Media
  • Financial Reports
  • Board of Directors/Management
  • Media Centre
  • Corporate Governance
  • Diversity Policy
  • Share Trading Policy
  • Interviews/Analyst Reports

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • Green Whistle gets the Green Light – FDA clears US Penthrox clinical trial

    2 March 2022 ASX ANNOUNCE...

  • MVP FY22 Half Year Results Investor Presentation

    25 February 2022 ASX anno...

  • MVP FY22 Half Year Report and Accounts

    24 February 2022 ASX Anno...

Healthcare Professional Registration

Login to access healthcare professional resources



Remember Me

Forgot password? | Register

Medical Developments International

Address:
4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: [email protected]
ABN: 14 106 340 667
For Medical Enquiries:

Phone: 1800 PENTHROX (1800 736 847)
Email: [email protected]

Email Newsletter